Clinical Trials Directory

Trials / Unknown

UnknownNCT06158217

Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Beijing Friendship Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Blood perfusion insufficiency and hypoxia are the main causes of drug resistance to chemotherapy in breast cancer. Increasing blood perfusion can improve drug delivery. The cavitation effect of ultrasound-stimulated microbubbles (USMBs) is known to enhance tumor blood perfusion, so we conducted a prospective human study to investigate the effects of USMBs on hemoperfusion in invasive breast cancer (IBC).

Detailed description

patients with IBC were selected from the breast surgery department of our hospital. To induce an enhanced perfusion effect, IBC tumors were treated with SonoVue® microbubbles (MBs) stimulated by ultrasound, with a mechanical index (MI) of 0.2-0.3; 1 mL of SonoVue® MBs were injected at 3.5-min intervals three times for a USMB treatment lasting 10 min. The contrast-enhanced ultrasound (CEUS) parameters peak intensity (PI), area under the curve (AUC), and perfusion area were used to evaluate the changes in blood perfusion.

Conditions

Interventions

TypeNameDescription
PROCEDUREultrasound combined with microbubblesIBC tumors were treated with microbubbles (MBs) stimulated by ultrasound

Timeline

Start date
2022-09-29
Primary completion
2025-05-06
Completion
2025-05-06
First posted
2023-12-06
Last updated
2023-12-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06158217. Inclusion in this directory is not an endorsement.